Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 7

Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial

Total article views   Abstract views HTML views PDF downloads Totals
16,234 Dovepress* 12,687 579+ 3,456 13,266
PubMed Central* 3 2,965 1,733 2,968
Totals 12,690 3,544 5,189 16,234
*Since 31 July 2012
+Since July 2016

View citations on PubMed Central and Google Scholar